Celularity Inc. Class A Share Price
NASDAQ: CELU | Micro CapCelularity Inc. Class A Stock Performance
Open $2.16 | Prev. Close $2.10 | Circuit Range N/A |
Day Range $1.51 - $2.17 | Year Range $0.57 - $3.90 | Volume 87,926 |
Average Traded $1.83 |
Celularity Inc. Class A Share Price Today
As of 31 August 2026, Celularity Inc. Class A's share price is $1.57. The stock opened at $2.16, compared to its previous close of $2.10. During today's trading session, Celularity Inc. Class A's share price traded between $1.51 and $2.17, with an average price of $1.84. Over the past 52 weeks, the stock has recorded a high of $3.90 and a low of $0.57. In terms of performance, Celularity Inc. Class A's share price has risen by 30.83% over the last six months and is down 59.74% on a year-on-year basis.
Celularity Inc. Class A Share Price Chart
Celularity Inc. Class A Stock Fundamentals & Key Indicators
Market Cap $27.97M | PE Ratio (TTM) -0.14 | Dividend Yield N/A |
EPS (TTM) $-11.02 | Revenue (TTM) $22.77M | Return On Equity (TTM) -479.24% |
Profit Margin -862.04% | Debt to Equity 2.51 | Quarterly Earnings Growth YoY -43.35% |
Celularity Inc. Class A Quarterly Profit & Loss
All figures in USD
Celularity Inc. Class A Annual Profit & Loss
All figures in USD
About Celularity Inc. Class A
Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Celularity Inc. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.72 | $2.13 | +204.29% |
Jul 2026 | $0.60 | $0.70 | +14.75% |
Jun 2026 | $1.00 | $0.61 | -37.76% |
May 2026 | $0.96 | $0.98 | -1.01% |
Apr 2026 | $1.30 | $0.99 | -25.00% |
Mar 2026 | $1.19 | $1.32 | +10.00% |
Feb 2026 | $1.25 | $1.20 | +0.00% |
Jan 2026 | $1.12 | $1.20 | +16.50% |
Dec 2025 | $2.04 | $1.03 | -47.98% |
Nov 2025 | $1.86 | $1.98 | +4.21% |
Oct 2025 | $2.11 | $1.90 | -8.21% |
Sep 2025 | $3.09 | $2.07 | -46.92% |
CELU Share Price FAQs
What is Celularity Inc. Class A share price today?
What is the 52 week high and 52 week low of Celularity Inc. Class A stock?
What is CELU's market capitalisation today?
What is CELU's net income for the last quarter?
What is the 5 year returns of CELU?
What is the high & low stock price of CELU today?
Can I buy CELU shares in India?